0
Abstract: Poster Presentations |

DIFFERENTIAL ELEVATION OF ENDOTHELIAL MICROPARTICLES AND THEIR BINDING TO LEUKOCYTES IN ACUTE CORONARY SYNDROMES FREE TO VIEW

Julio A. Chirinos, MD*; Eduardo De Marchena, MD; Alex Ferreira, MD; Carlos Alfonso, MD; Anila Veerani, MD; Arley Peter, MD; Rene Parraga, MD; Wenche Jy, PhD; Joaquin J. Jimenez, MD; Lawrence Horstman, BS; Yeon S. Ahn, MD
Author and Funding Information

University of Miami, Miami, FL



Chest. 2006;130(4_MeetingAbstracts):190S. doi:10.1378/chest.128.6_suppl.618S
Text Size: A A A
Published online

Abstract

PURPOSE: Endothelial microparticles (EMP) are small membrane vesicles released by activated or apoptotic endothelial cells. Recent studies indicate that different species of EMP reflect different biologic processes and exert different biologic functions. Furthermore, some species bind and activate leukocytes. The purpose of our study was to examine different phenotypic species of circulating EMP and EMP-leukocyte (EMP-L) conjugates among patients with acute coronary syndromes (ACS).

METHODS: We studied 40 patients with ACS and compared them to 22 healthy controls. Using flow cytometry, we measured EMP identified by E-selectin (EMP62E), CD51 (EMP51) and CD54 (EMP54). Free EMP levels are expressed in counts/μL). EMP62E- and EMP54-leukocyte conjugates were measured by the detection of E-selectin (CD62E) or CD54, respectively, co-expressed with CD45 in leukocytes and are expressed as fluorescence intensity units (FLIU).

RESULTS: Compared to controls, patients with ACS had significantly higher levels of free EMP51 (332 vs. 119 counts/μL; p=0.02) but similar levels of EMP54 and EMP62E. However, patients with ACS had significantly higher levels of EMP54-monocyte (1.99 vs. 1.19 FLIU; p<0.001), EMP54-neutrophil (2.00 vs. 1.46; p=0.003) and EMP54-lymphocyte (1.26 vs. 1.21; p=0.02)conjugates. Patients with ACS also demonstrated significantly elevated levels of CD62E-lymphocyte (1.20 vs.1.14 FLIU; p=0.02)and EMP62E-monocyte (1.85 vs. 1.32; p<0.0001) conjugates.

CONCLUSION: Increased binding of EMP to leukocytes occurs in ACS, which may promote thrombosis and inflammation through its known effects on leukocyte activation and tissue-factor activity. Increased binding to leukocytes also results in normal levels of the free form of some EMP species. Analysis of free EMP is therefore limited and concomitant assessment of EMP-L conjugates is important.

CLINICAL IMPLICATIONS: Binding of EMP to leukocytes may represent a risk marker as well as a novel therapeutic target in ACS.

DISCLOSURE: Julio Chirinos, None.

Wednesday, October 25, 2006

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543